Pricing Log in Create free account

CeriBell, Inc. (CBLL) vs PROCEPT BioRobotics Corporation (PRCT)

CeriBell, Inc. and PROCEPT BioRobotics Corporation are both Medical Devices companies. PROCEPT BioRobotics Corporation is the larger, with a market value of $1.2B against $1.0B — 1.1× the size. CeriBell, Inc. grew revenue faster over the last twelve months: 31.3% against 17.5%. PROCEPT BioRobotics Corporation has the higher net margin (−32.6% vs −68.0%) and the higher return on invested capital (−45.6% vs −236.3%). Across the 17 metrics below, PROCEPT BioRobotics Corporation leads on 10 and CeriBell, Inc. on 7.

Valuation

Metric CBLL PRCT Medical Devices median
P/E n/m n/m 25.58
P/S 9.21 3.27 2.54
P/B 8.52 3.51 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 8.31 2.81 2.72
Earnings yield (7.48%) (10.04%) (12.82%)
Free cash flow yield (5.83%) (7.38%) (8.18%)

Profitability

Metric CBLL PRCT Medical Devices median
Gross margin 89.26% 64.66% 57.76%
Operating margin (69.79%) (33.61%) (15.07%)
Net margin (67.96%) (32.60%) (14.45%)
Free cash flow margin (53.69%) (24.15%) (3.88%)
Return on equity (52.47%) (32.39%) (10.35%)
Return on assets (41.52%) (23.31%) (17.26%)
Return on invested capital (236.27%) (45.60%) (5.27%)

Growth

Metric CBLL PRCT Medical Devices median
Revenue growth (TTM) 31.28% 17.47% 10.41%
EPS growth (last fiscal year) 56.93% 1.71% 28.17%
Revenue growth, 5-year CAGR — 109.04% 15.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CBLL PRCT Medical Devices median
Debt to equity 0.17 0.16 0.04
Current ratio 8.18 5.89 2.74
Net debt to EBITDA 2.38 2.41 0.54

Dividend

Metric CBLL PRCT Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric CBLL PRCT Medical Devices median
Market cap 1.01b 1.16b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack